BNP looks like a winner
Natriuretic peptides are out of the research laboratory and into the clinic and hospital ward.
J.D. CLOUGH

How to assess and counsel the older driver
Suggesting that a patient stop driving is never easy, yet taking no action may have deadly consequences.
B.J. MESSINGER-RAPPORT

A 52-year-old man with excessive daytime sleepiness
What is the cause of this patient’s symptoms? A self-test.
B.D. SARODIA, R. MEHRA, and J.A. GOLISH

Oncologic emergencies for the internist
The complications the general internist is most likely to see and can least afford to miss.
W.S. KRIMSKY, R.J. BEHRENS, and G.J. KERKVLIET

Hereditary hemochromatosis: A common, often unrecognized genetic disease
Although hereditary hemochromatosis is one of the most common genetic diseases affecting people of northern European descent, it is underdiagnosed.
G.M. McCARTHY, C.J. McCARTHY, D. KENNY, J. CROWE, and S. EUSTACE

Hereditary hemochromatosis: Molecular genetic testing issues for the clinician
A DNA test exists, but who should be tested?
B.A. CLARK

The rapid natriuretic peptide assay: A rapid test for heart failure 
This 15-minute test is highly sensitive and fairly specific and is useful in evaluating suspected heart failure in outpatients and in emergency care.
W.F. PEACOCK

How to use nesiritide in treating decompensated heart failure
Nesiritide, a recombinant formulation of BNP, is the first new parenteral drug in more than a decade to be approved for treating heart failure.
R.M. MILLS and R.E. HOBBS

  What is the best diagnostic approach when pheochromocytoma is suspected?
First prove there is catecholamine overproduction, then obtain an MRI to locate the tumor.
E.L. BRAVO

  What is the best way to determine if thrombocytopenia in a patient on multiple medications is drug-induced?
The only way is to stop the suspected drug and see if the thrombocytopenia resolves. But how to avoid stopping needed drugs that are not a problem?
N.S. MAJHAIL and A.E. LICHTIN